E-LIB Suche - Ergebnisse für: Hehlmann, R

1

Erratum: Expression of the CTLA-4 ligand CD86 on plasmacyto..:

Schütz, C ; Inselmann, S ; Saussele, S...
Leukemia. 32 (2018) 4 - p. 1053-1053 , 2018

Link: https://doi.org/10.1038/..

2

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendri..:

Schütz, C ; Inselmann, S ; Sausslele, S...
Leukemia. 31 (2017) 4 - p. 829-836 , 2017

Link: https://doi.org/10.1038/..

3

Assessment of imatinib as first-line treatment of chronic m..:

for the SAKK and the German CML Study Group ; Hehlmann, R ; Lauseker, M...
Leukemia. 31 (2017) 11 - p. 2398-2406 , 2017

Link: https://doi.org/10.1038/..

4

Imatinib Discontinuation and Tki Switching Patterns in the ..:

Zyczynski, T ; Khoury, J ; Goldberg, S...
Value in Health. 19 (2016) 7 - p. A894-A895 , 2016

Link: https://doi.org/10.1016/..

5

Secondary malignancies in chronic myeloid leukemia patients..:

Miranda, M B ; Lauseker, M ; Kraus, M-P...
Leukemia. 30 (2016) 6 - p. 1255-1262 , 2016

Link: https://doi.org/10.1038/..

6

European LeukemiaNet recommendations for the management and..:

Steegmann, J L ; Baccarani, M ; Breccia, M...
Leukemia. 30 (2016) 8 - p. 1648-1671 , 2016

Link: https://doi.org/10.1038/..

7

Myeloproliferative neoplasms and inflammation: whether to t..:

Koschmieder, S ; Mughal, T I ; Hasselbalch, H C...
Leukemia. 30 (2016) 5 - p. 1018-1024 , 2016

Link: https://doi.org/10.1038/..

8

Age, not therapy intensity, determines outcomes of adults w..:

Büchner, T ; Krug, U O ; Peter Gale, R...
Leukemia. 30 (2016) 8 - p. 1781-1784 , 2016

Link: https://doi.org/10.1038/..

9

Prof. Thomas Büchner (22 September 1934–5 August 2016)—A le..:

Berdel, W E ; Hehlmann, R ; Hoelzer, D.
Leukemia. 30 (2016) 11 - p. 2131-2132 , 2016

Link: https://doi.org/10.1038/..

10

Increasing intensity of therapies assigned at diagnosis doe..:

Krug, U ; Berdel, W E ; Gale, R P...
Leukemia. 30 (2016) 6 - p. 1230-1236 , 2016

Link: https://doi.org/10.1038/..

11

Which patients with myelofibrosis should receive ruxolitini..:

Marchetti, M ; Barosi, G ; Cervantes, F...
Leukemia. 31 (2016) 4 - p. 882-888 , 2016

Link: https://doi.org/10.1038/..

12

Re-emergence of interferon-α in the treatment of chronic my..:

Talpaz, M ; Hehlmann, R ; Quintás-Cardama, A..
Leukemia. 27 (2012) 4 - p. 803-812 , 2012

Link: https://doi.org/10.1038/..

13

Moderne Therapie der chronisch myeloischen Leukämie: Ein Be..:

Leitner, A.A. ; Hehlmann, R.
Der Internist. 52 (2011) 2 - p. 209-217 , 2011

Link: https://doi.org/10.1007/..

14

Erratum zu:: Moderne Therapie der chronisch myeloischen Leu..:

Leitner, A.A. ; Hehlmann, R.
Der Internist. , 2011

Link: https://doi.org/10.1007/..

15

Introduction: CML in the imatinib era:

Hehlmann, R.
Best Practice & Research Clinical Haematology. 22 (2009) 3 - p. 283-284 , 2009

Link: https://doi.org/10.1016/..